These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7011731)

  • 21. Binding, membrane redistribution, internalization and lysosomal association of [125I]anti-insulin receptor antibody in IM-9-cultured human lymphocyte. A comparison with [125I]insulin.
    Carpentier JL; van Obberghen E; Gordon P; Orci L
    Exp Cell Res; 1981 Jul; 134(1):81-92. PubMed ID: 7018914
    [No Abstract]   [Full Text] [Related]  

  • 22. Biologic activity and pharmacokinetics of biosynthetic human insulin in the rat.
    Halban PA; Berger M; Gjinovci A; Renold AE
    Diabetes Care; 1981; 4(2):238-43. PubMed ID: 7011735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity alteration of insulin receptor induced by a phorbol ester.
    Grunberger G; Gorden P
    Am J Physiol; 1982 Oct; 243(4):E319-24. PubMed ID: 6751097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-binding kinetics of A-14 and A-19 125I-labelled insulin.
    Watanabe N; Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y
    Biochim Biophys Acta; 1984 Apr; 798(3):313-6. PubMed ID: 6370314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular potassium depletion in IM-9 lymphocytes suppresses the slowly dissociating component of human growth hormone binding and the down-regulation of its receptors but does not affect insulin receptors.
    Ilondo MM; Courtoy PJ; Geiger D; Carpentier JL; Rousseau GG; De Meyts P
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6460-4. PubMed ID: 3018733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of a monoclonal antibody to the insulin receptor with receptors for insulin-like growth factors.
    Roth RA; Maddux B; Wong KY; Styne DM; Van Vliet G; Humbel RE; Goldfine ID
    Endocrinology; 1983 May; 112(5):1865-7. PubMed ID: 6299712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic properties of biosynthetic human insulin in vitro.
    Beischer W; Maier V; Jonatha EM; Hartweg D; Kratzsch G
    Diabetes Care; 1981; 4(2):202-4. PubMed ID: 7011727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin binding to human cultured lymphocytes measured by flow cytometry using three ligands.
    Ziegler O; Cantin C; Germain L; Dupuis M; Sekaly RP; Drouin P; Chiasson JL
    Cytometry; 1994 Aug; 16(4):339-45. PubMed ID: 7988295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin receptor internalization and recycling: mechanism and significance.
    Carpentier JL; Fehlmann M; Van Obberghen E; Gorden P; Orci L
    Biochimie; 1985; 67(10-11):1143-5. PubMed ID: 3907718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography.
    Frank BH; Peavy DE; Hooker CS; Duckworth WC
    Diabetes; 1983 Aug; 32(8):705-11. PubMed ID: 6347767
    [No Abstract]   [Full Text] [Related]  

  • 32. The cellular distribution of A14-(125I)monoiodoinsulin after incubation with cultured human lymphocytes (IM-0). A quantitative electronmicroscope autoradiographic study.
    Christensen EI; Rennie P; Gliemann J
    Cell Biol Int Rep; 1982 Aug; 6(8):757-65. PubMed ID: 6751567
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of phenformin and other adenosine triphosphate (ATP)-lowering agents on insulin binding to IM-9 human cultured lymphocytes.
    Vigneri R; Maddux B; Goldfine ID
    J Cell Biochem; 1984; 24(2):177-86. PubMed ID: 6327744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supernormal insulin: [D-PheB24]-insulin with increased affinity for insulin receptors.
    Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y; Inouye K
    Biochem Biophys Res Commun; 1982 Jul; 107(1):329-36. PubMed ID: 6751328
    [No Abstract]   [Full Text] [Related]  

  • 35. Binding and degradation of semisynthetic tritiated insulin by IM-9 cultured human lymphocytes.
    Misbin RI; Davies JG; Offord RE; Halban PA; Mehl TD
    Diabetes; 1980 Sep; 29(9):730-5. PubMed ID: 7002687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
    Kobayashi M; Sasaoka T; Sugibayashi M; Iwanishi M; Shigeta Y
    Diabetes Res Clin Pract; 1989 Jun; 7(1):25-8. PubMed ID: 2666066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic hormone receptors on islet cells.
    Van Schravendijk CF; Foriers A; Hooghe-Peters EL; Rogiers V; De Meyts P; Sodoyez JC; Pipeleers DG
    Endocrinology; 1985 Sep; 117(3):841-8. PubMed ID: 2990873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin receptors of cultured human lymphocytes (IM-9). Lack of receptor-mediated degradation.
    Sonne O; Gliemann J
    J Biol Chem; 1980 Aug; 255(15):7449-54. PubMed ID: 6993488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced binding affinity of chicken insulin in rat liver membranes and human lymphocytes: relationship tothe kinetic properties of the hormone- receptor interaction.
    Simon J; Freychet P; Rosselin G; DeMeyts P
    Endocrinology; 1977 Jan; 100(1):115-21. PubMed ID: 830534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin binding and degradation studies on erythrocytes at different temperatures.
    Dwenger A; Zick R
    Biochim Biophys Acta; 1984 Mar; 798(1):132-6. PubMed ID: 6367828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.